Please login to the form below

Not currently logged in
Email:
Password:

EAHP elects Joan Peppard as president

She will replace Roberto Frontini next year

Joan-Peppard-EAHPJoan Peppard was this week elected to the role of president of the European Association of Hospital Pharmacists (EAHP).

She will take over from Roberto Frontini in June 2015, when she will begin a three-year term at the helm of the EAHP, which serves as an association for national organisations that represent hospital pharmacists.

Peppard currently serves on the EAHP board as director of professional development, has twice headed up the Hospital Pharmacists Association of Ireland as its president and is also a chief pharmacist in a hospital in Ireland.

As president of the EAHP, Peppard will look to advance the organisation's mission to develop hospital pharmacy in order to promote the best and safest use of medicines and medical devices and to create a platform for the education and training of hospital pharmacists.

Among her most pressing concerns is the implementation of new European Statements of Hospital Pharmacy, which were agreed in May this year and set out a robust set of hospital pharmacy practice standards for Europe.

“[T]he number one challenge for the forthcoming EAHP Board is evident,” said Peppard, “how to turn that clear vision for the future of the profession into a reality in every European country.

“I know we have the commitment, insight and enthusiasm to achieve it.”

26th June 2014

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...